...Ultra-high risk CLL (Meets at least one of the following criteria): (1) ultra high-risk genetics (17p deletion and/or TP53 mutation); (2) short PFS (<24 months) after intense immunochemotherapy treatment(i.e. FCR, FR, PCR, BR etc); (3) fludarabine-frfratory; 5. ...